Research On The Strategy And Effect Of Blue Sail Medical’s Cross-border Merger And Acquisition

With the increasingly fierce market competition and the gradual saturation of market scale,many enterprises choose the means of business layout in new areas to promote their own enterprise development in order to obtain more benefits.However,due to the high barriers in high-tech fields,many enterprises choose to use the form of merger and acquisition transactions to shorten the R & D cycle of high-tech,smoothly enter the new market and carry out business.With the development of globalization,more and more domestic enterprises acquire a higher level of production technology or a broader global market through mergers and acquisitions of foreign enterprises.Although the domestic medical device industry has a larger scale development potential with the development of aging society.The new era puts forward stricter,more standardized,more refined and more humanized requirements for medical devices in China.The medical device industry is facing a new pattern of opportunities and challenges.With the growing demand for medical diversification and the relatively high demand elasticity and business risk of the medical device industry itself,it is difficult to resist the attack of emerging industries such as peer enterprises,circulation enterprises and new Internet enterprises.Therefore,medical device enterprises are more and more committed to integrating resources,extending the industrial chain and expanding the scope of business.M & A is an important development mode for their stability and expansion.This paper analyzes the M & a strategy and M & A effect of lanfan medical company in order to provide experience and Enlightenment for the M & A of medical device industry.From the formal establishment of A-share medical device sector to now,the event selected in this study is the highest and largest acquisition in the whole period of time in terms of scale and transaction amount.Before the merger,it can be found that lanfan medical has no advantage compared with Parkson international in terms of net valuation or net profit,but after more than 600 days and nights of research In the end,the classic Snake swallowing elephant transaction was successfully completed,and lanfan international finally successfully occupied more than 90% of the shares of Parkson international.There are many complex factors in this event,so research on it can provide a theoretical basis for other companies in the process of mergers and anti-mergers.This thesis is composed of six chapters.The first chapter is the introduction of the paper,and the second part is a literature review.It organizes the research of domestic and foreign scholars from three perspectives:the effects of cross-border mergers and acquisitions strategies,the motivations of cross-border mergers and acquisitions,and the effects of mergers and acquisitions;The three parts are the status quo analysis.The analysis is mainly based on the overview,current situation and characteristics of my country’s medical device industry;the fourth part is an overview of the case of Blue Sail Medical’s acquisition of Bosheng International.First determine that Bluesail Medical will achieve diversified strategic goals by implementing cross-border M&A strategies,and then further clarify the target company,and then explain the motivations,processes and risks of Bluesail Medical’s acquisition of Bosheng International;the fifth part is to analyze the effects of the merger,use the event research method and the comprehensive analysis method of financial performance to measure the effect of corporate mergers and acquisitions;the sixth part is the conclusion and enlightenment.After the research,the author can confirm that this M & A is a very successful leverage trade for lanfan medical.After the completion of the M & A,the short-term performance of lanfan medical in the market has improved significantly and rapidly.After the completion of the M & A,lanfan medical can provide more diversified business and improve the degree of diversification of business structure,and the diversification strategic objectives have been achieved,Lanfan medical has realized the industrial upgrading from low value consumables business to high value consumables business.